Yth m6A RNA-Binding Protein 1 Regulates Osteogenesis of MC3T3-E1 Cells under Hypoxia via Translational Control of Thrombospondin-1

Diwen Shi, Xiaohan Liu, Xinyun Li, Tian Li, Jie Liu, Lin WuInternational Journal of Molecular Sciences 2023 · DOI

TL;DR

This study reveals how hypoxia, a common condition in peri-implantitis, impairs bone cell (osteoblast) differentiation. The researchers found that a specific RNA-binding protein, YTHDF1, is upregulated under hypoxia and plays a crucial role in counteracting this impairment by stabilizing the mRNA of Thrombospondin-1 (THBS1), a protein involved in bone formation. This discovery highlights a novel therapeutic target for treating bone loss associated with peri-implantitis.

What Problem Does This Paper Address?

Peri-implantitis, an inflammatory condition around dental implants, is a leading cause of implant failure. A key factor contributing to this problem is the development of hypoxic (low oxygen) environments in the tissues surrounding the implant. This hypoxia is thought to negatively impact bone regeneration and maintenance, potentially leading to bone loss and implant failure. While the general role of N6-methyladenosine (m<sup>6</sup>A) RNA modification in biological processes is known, the specific mechanisms by which it influences osteoblast differentiation under hypoxic conditions, particularly in the context of peri-implantitis, remained unclear. This paper aims to elucidate the role of YTHDF1, a key "reader" protein for m<sup>6</sup>A modifications, in osteogenic differentiation under hypoxia and identify its downstream targets.

Methods

The researchers employed a multi-pronged approach:

  • Cell Culture and Hypoxia Induction: MC3T3-E1 osteoblast cells were cultured under varying oxygen concentrations (21% for normoxia, 5% and 1% for hypoxia) to mimic peri-implantitis conditions.
  • Gene Expression Analysis: Quantitative real-time PCR (qRT-PCR) and Western blotting were used to measure the expression levels of key genes and proteins, including YTHDF1, HIF-1α (a hypoxia marker), and osteogenic markers like ALP, RUNX2, and COL1.
  • Loss-of-Function Studies: Short interfering RNA (siRNA) was used to knock down the expression of YTHDF1 and THBS1 to assess their roles in osteogenesis.
  • Bioinformatics Analysis: Tools like SRAMP and PRIdictor were used to predict m<sup>6</sup>A modification sites on THBS1 mRNA and potential binding sites for YTHDF1. Gene Ontology (GO) analysis was performed to understand the biological processes associated with YTHDF1-regulated genes.
  • mRNA Stability Assays: Actinomycin D was used to inhibit transcription and assess the stability of THBS1 mRNA under different conditions.
  • Immunofluorescence Microscopy: This technique was used to visualize the cellular localization of YTHDF1 and THBS1 and confirm their co-localization under hypoxia.
  • Functional Assays: Alkaline phosphatase (ALP) activity assays and Alizarin Red S (ARS) staining were performed to evaluate the osteogenic differentiation and mineralization capabilities of the cells.
  • Overexpression Studies: YTHDF1 was overexpressed using a plasmid to further investigate its role and its interaction with THBS1.

Datasets

The study utilized the GSE33774 microarray dataset from the Gene Expression Omnibus (GEO) database to evaluate the differential expression of YTHDF1 in normal and peri-implantitis tissues.

Key Insights and Ideas

  • Hypoxia is a double-edged sword for YTHDF1: While hypoxia suppresses osteogenic differentiation, it paradoxically increases the expression of YTHDF1. This suggests YTHDF1 might be a cellular response to mitigate hypoxia's negative effects.
  • YTHDF1 is a key player in osteogenesis under stress: Knocking down YTHDF1 significantly worsened the inhibitory effects of hypoxia on osteoblast differentiation, indicating YTHDF1's protective role.
  • THBS1 is the critical downstream target: Bioinformatics and experimental data strongly point to Thrombospondin-1 (THBS1) as a direct target of YTHDF1. YTHDF1 appears to regulate THBS1 at the post-transcriptional level.
  • m<sup>6</sup>A-dependent translational control: YTHDF1 enhances THBS1 mRNA stability, leading to increased THBS1 protein levels. This translational control is mediated by m<sup>6</sup>A modification, suggesting a sophisticated regulatory mechanism.
  • Co-localization under hypoxia: YTHDF1 and THBS1 were found to co-localize in the cytoplasm of cells under hypoxic conditions, further supporting their functional interaction.

Key Results

  • Hypoxia (1% O2 for 24h) significantly suppressed osteogenic differentiation markers (ALP, RUNX2, COL1), ALP activity, and ARS staining in MC3T3-E1 cells.
  • Hypoxia significantly upregulated YTHDF1 mRNA and protein expression in a time-dependent manner.
  • Knockdown of YTHDF1 in MC3T3-E1 cells led to decreased expression of osteogenic markers and reduced ALP activity and ARS staining, both under normoxia and hypoxia. The effect was more pronounced under hypoxia.
  • Bioinformatics analysis identified THBS1 as a potential downstream target of YTHDF1, with predicted m<sup>6</sup>A sites and YTHDF1 binding regions on THBS1 mRNA.
  • Silencing YTHDF1 reduced THBS1 mRNA and protein levels and decreased THBS1 mRNA stability.
  • Knocking down THBS1 alone also inhibited osteogenic differentiation, particularly under hypoxia, and its effect was exacerbated when YTHDF1 was also knocked down.
  • Overexpression of YTHDF1 promoted osteogenic differentiation and THBS1 expression, and this effect was attenuated when THBS1 was simultaneously knocked down.

Limitations and Future Work

The authors acknowledge several limitations and suggest future directions:

  • Broader YTHDF1 Targets: The study focused on THBS1, but YTHDF1 may regulate other downstream targets that contribute to osteogenesis under hypoxia. Further research is needed to identify these.
  • THBS1 Mechanism in Hypoxia: While THBS1's role in osteogenesis under hypoxia is demonstrated, the precise molecular mechanisms by which THBS1 itself promotes osteogenesis in this context require further exploration.
  • In Vivo Validation: The findings were primarily based on in vitro studies using cell lines. In vivo studies are crucial to validate these findings in a more complex biological system and to assess the therapeutic potential of targeting the YTHDF1/THBS1 pathway in peri-implantitis models.

Summary updated

Abstract

Peri-implantitis is a major factor affecting implant prognosis, and the specific anatomy of the peri-implant area makes it more vulnerable to the local hypoxic environment caused by inflammation. N6-methyladenosine (m<sup>6</sup>A) plays a vital role in a multitude of biological processes, and its main "reader" Yth m<sup>6</sup>A RNA-binding protein 1 (YTHDF1) is suggested to affect osteogenic differentiation. However, the mechanism underlying the effect of YTHDF1 on osteogenic differentiation under hypoxic conditions remains unclear. To address this question, we examined the expression of YTHDF1 under hypoxia and observed that hypoxia suppressed osteogenic differentiation but promoted the expression of YTHDF1. Then we knocked down YTHDF1 and found decreased levels of osteogenic-related markers, alkaline phosphatase (ALP) activity, and alizarin red staining (ARS) under normoxia or hypoxia treatment. Bioinformatics analysis identified Thrombospondin-1 (THBS1) might be a downstream factor of YTHDF1. The results revealed that YTHDF1 enhanced the stability of THBS1 mRNA, and immunofluorescence assays found co-localization with YTHDF1 and THBS1 under hypoxia. Loss of function studies showed knocking down YTHDF1 or THBS1 exacerbated the osteogenic inhibition caused by hypoxia. All data imply that hypoxia suppresses osteogenic differentiation and promotes the expression of YTHDF1, which translationally regulates THBS1 in an m<sup>6</sup>A-dependent manner, potentially counteracting hypoxia-induced osteogenic inhibition through the YTHDF1/THBS1 pathway. The results of this study reveal for the first time the molecular mechanism of the regulation of osteogenic differentiation by YTHDF1 under hypoxia and suggest that YTHDF1, together with its downstream factor THBS1, may be critical targets to counteract osteogenic inhibition under hypoxic conditions, providing promising therapeutic strategy for the hypoxia-induced bone loss in peri-implantitis.
BibTeX
@article{shi2023yth,
  author = {Diwen Shi and Xiaohan Liu and Xinyun Li and Tian Li and Jie Liu and Lin Wu},
  title = {{Yth m6A RNA-Binding Protein 1 Regulates Osteogenesis of MC3T3-E1 Cells under Hypoxia via Translational Control of Thrombospondin-1}},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021741},
}
Figure